Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Article uri icon

Overview

publication date

  • October 13, 2009

Research

keywords

  • Amyotrophic Lateral Sclerosis
  • Insulin-Like Growth Factor I

Identity

Scopus Document Identifier

  • 70350146791

Digital Object Identifier (DOI)

  • 10.1212/WNL.0b013e3181b26ae6

PubMed ID

  • 19822878

Additional Document Info

volume

  • 73

issue

  • 15